Highlights and Quick Summary
- Capex/Depreciation for the quarter ending September 30, 2022 was -46.04 (a 477.99% increase compared to previous quarter)
- Year-over-year quarterly Capex/Depreciation increased by 790.96%
- Annual Capex/Depreciation for 2021 was -6.35 (a 88.29% increase from previous year)
- Annual Capex/Depreciation for 2020 was -3.37 (a -30.45% decrease from previous year)
- Annual Capex/Depreciation for 2019 was -4.85 (a -76.0% decrease from previous year)
- Twelve month Capex/Depreciation ending September 30, 2022 was -6.37 (a 31.98% increase compared to previous quarter)
- Twelve month trailing Capex/Depreciation increased by 0.43% year-over-year
Trailing Capex/Depreciation for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -6.37 | -4.83 | -4.79 | -6.35 |
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex/Depreciation of Beam Therapeutics Inc.
Most recent Capex/Depreciationof BEAM including historical data for past 10 years.Interactive Chart of Capex/Depreciation of Beam Therapeutics Inc.
Beam Therapeutics Inc. Capex/Depreciation for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -46.04 | -7.97 | -2.48 | – |
| 2021 | -5.17 | -3.35 | -9.8 | -8.12 | -6.35 |
| 2020 | -6.06 | -2.06 | -2.02 | -3.14 | -3.37 |
| 2019 | -2.87 | -2.49 | -12.52 | -3.2 | -4.85 |
| 2018 | – | – | – | -20.19 | -20.19 |
| 2017 | – | – | – | – | 0.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology